Stock listing

PLRX Stock Price, News, Filings & Events — Pliant Therapeutics, Inc.

Selected listing: PLRX · BOATS · USD · US

This page tracks Pliant Therapeutics, Inc.'s PLRX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PLRX:BOATS. PLRX:BOATS is the stock-level entry point for investors researching Pliant Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pliant Therapeutics, Inc. is a public company traded under the ticker PLRX on the American market. The company has a market capitalization of approximately $67.5 million. Pliant focuses on developing innovative therapies for fibrotic diseases, aiming to address significant unmet medical needs.

PLRX:BOATSUSDUSUpdated September 11, 2026
Pliant Therapeutics, Inc. logo
Ticker
PLRX:BOATS
Asset type
Stock
Market cap
$72.4M
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Pliant Therapeutics, Inc. PLRX:BOATS stock context

This page tracks Pliant Therapeutics, Inc.'s PLRX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PLRX:BOATS. PLRX:BOATS is the stock-level entry point for investors researching Pliant Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pliant Therapeutics, Inc. is a public company traded under the ticker PLRX on the American market. The company has a market capitalization of approximately $67.5 million. Pliant focuses on developing innovative therapies for fibrotic diseases, aiming to address significant unmet medical needs.

Latest news from Pliant Therapeutics, Inc.

All Pliant Therapeutics, Inc. news →

Research Pliant Therapeutics, Inc.

Alternate listings